CTPS2
CTP synthase 2
Also known as: GATD5B, PYRG2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NRF8
- Gene
- CTPS2
- Ensembl
- ENSG00000047230
- Chromosome
- X
- Canonical length
- 586 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Mitochondria,Cytosol
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
The protein encoded by this gene catalyzes the formation of CTP from UTP with the concomitant deamination of glutamine to glutamate. This protein is the rate-limiting enzyme in the synthesis of cytosine nucleotides, which play an important role in various metabolic processes and provide the precursors necessary for the synthesis of RNA and DNA. Cancer cells that exhibit increased cell proliferation also exhibit an increased activity of this encoded protein. Thus, this protein is an attractive target for selective chemotherapy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
Canonical amino-acid sequenceUniProt
586 residues, UniProt reviewed canonical sequence.
>Q9NRF8|CTPS2
1 MKYILVTGGV ISGIGKGIIA SSIGTILKSC GLRVTAIKID PYINIDAGTF SPYEHGEVFV
61 LNDGGEVDLD LGNYERFLDI NLYKDNNITT GKIYQHVINK ERRGDYLGKT VQVVPHITDA
121 VQEWVMNQAK VPVDGNKEEP QICVIELGGT IGDIEGMPFV EAFRQFQFKA KRENFCNIHV
181 SLVPQLSATG EQKTKPTQNS VRALRGLGLS PDLIVCRSST PIEMAVKEKI SMFCHVNPEQ
241 VICIHDVSST YRVPVLLEEQ SIVKYFKERL HLPIGDSASN LLFKWRNMAD RYERLQKICS
301 IALVGKYTKL RDCYASVFKA LEHSALAINH KLNLMYIDSI DLEKITETED PVKFHEAWQK
361 LCKADGILVP GGFGIRGTLG KLQAISWART KKIPFLGVCL GMQLAVIEFA RNCLNLKDAD
421 STEFRPNAPV PLVIDMPEHN PGNLGGTMRL GIRRTVFKTE NSILRKLYGD VPFIEERHRH
481 RFEVNPNLIK QFEQNDLSFV GQDVDGDRME IIELANHPYF VGVQFHPEFS SRPMKPSPPY
541 LGLLLAATGN LNAYLQQGCK LSSSDRYSDA SDDSFSEPRI AELEISLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CTPS2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 12 nTPM
Expression across tissuesHPA
Tissue
- duodenum: 12 nTPM
- ovary: 12 nTPM
- parathyroid gland: 11 nTPM
- breast: 9.7 nTPM
- small intestine: 9.7 nTPM
- endometrium: 9.6 nTPM
Single-cell type
- enterocytes: 79 nCPM
- hematopoietic stem cells: 69 nCPM
- mast cells: 69 nCPM
- thymocytes: 69 nCPM
- myonuclei: 65 nCPM
- fibro-adipogenic progenitors: 64 nCPM
Immune cell
- non-classical monocyte: 2.8 nTPM
- NK-cell: 1.7 nTPM
- myeloid DC: 1.3 nTPM
- MAIT T-cell: 0.9 nTPM
- plasmacytoid DC: 0.9 nTPM
- T-reg: 0.9 nTPM
Brain region
- white matter: 18 nTPM
- medulla oblongata: 16 nTPM
- cerebellum: 15 nTPM
- basal ganglia: 14 nTPM
- hypothalamus: 14 nTPM
- pons: 14 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.39
- gnomAD pLI
- 0.82
- gnomAD missense Z
- 2.59
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- 'de novo' CTP biosynthetic process
- CTP biosynthetic process
- pyrimidine nucleobase biosynthetic process
- pyrimidine nucleotide metabolic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CTPS2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CTPS2 as an antibody target. Whether an autoantibody or antibody against CTPS2 could matter depends on whether native CTPS2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CTPS2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CTPS2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...